430 related articles for article (PubMed ID: 29555466)
1. Non-targeted metabolomic biomarkers and metabotypes of type 2 diabetes: A cross-sectional study of PREDIMED trial participants.
Urpi-Sarda M; Almanza-Aguilera E; Llorach R; Vázquez-Fresno R; Estruch R; Corella D; Sorli JV; Carmona F; Sanchez-Pla A; Salas-Salvadó J; Andres-Lacueva C
Diabetes Metab; 2019 Apr; 45(2):167-174. PubMed ID: 29555466
[TBL] [Abstract][Full Text] [Related]
2. Olive oil consumption, plasma metabolites, and risk of type 2 diabetes and cardiovascular disease.
García-Gavilán JF; Babio N; Toledo E; Semnani-Azad Z; Razquin C; Dennis C; Deik A; Corella D; Estruch R; Ros E; Fitó M; Arós F; Fiol M; Lapetra J; Lamuela-Raventos R; Clish C; Ruiz-Canela M; Martínez-González MÁ; Hu F; Salas-Salvadó J; Guasch-Ferré M
Cardiovasc Diabetol; 2023 Dec; 22(1):340. PubMed ID: 38093289
[TBL] [Abstract][Full Text] [Related]
3. Plasma metabolite profile of legume consumption and future risk of type 2 diabetes and cardiovascular disease.
Margara-Escudero HJ; Paz-Graniel I; García-Gavilán J; Ruiz-Canela M; Sun Q; Clish CB; Toledo E; Corella D; Estruch R; Ros E; Castañer O; Arós F; Fiol M; Guasch-Ferré M; Lapetra J; Razquin C; Dennis C; Deik A; Li J; Gómez-Gracia E; Babio N; Martínez-González MA; Hu FB; Salas-Salvadó J
Cardiovasc Diabetol; 2024 Jan; 23(1):38. PubMed ID: 38245716
[TBL] [Abstract][Full Text] [Related]
4. Plasma metabolite profiles associated with the World Cancer Research Fund/American Institute for Cancer Research lifestyle score and future risk of cardiovascular disease and type 2 diabetes.
Rios S; García-Gavilán JF; Babio N; Paz-Graniel I; Ruiz-Canela M; Liang L; Clish CB; Toledo E; Corella D; Estruch R; Ros E; Fitó M; Arós F; Fiol M; Guasch-Ferré M; Santos-Lozano JM; Li J; Razquin C; Martínez-González MÁ; Hu FB; Salas-Salvadó J
Cardiovasc Diabetol; 2023 Sep; 22(1):252. PubMed ID: 37716984
[TBL] [Abstract][Full Text] [Related]
5. High plasma glutamate and low glutamine-to-glutamate ratio are associated with type 2 diabetes: Case-cohort study within the PREDIMED trial.
Liu X; Zheng Y; Guasch-Ferré M; Ruiz-Canela M; Toledo E; Clish C; Liang L; Razquin C; Corella D; Estruch R; Fito M; Gómez-Gracia E; Arós F; Ros E; Lapetra J; Fiol M; Serra-Majem L; Papandreou C; Martínez-González MA; Hu FB; Salas-Salvadó J
Nutr Metab Cardiovasc Dis; 2019 Oct; 29(10):1040-1049. PubMed ID: 31377179
[TBL] [Abstract][Full Text] [Related]
6. Metabolomics of Type 1 and Type 2 Diabetes.
Arneth B; Arneth R; Shams M
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31109071
[TBL] [Abstract][Full Text] [Related]
7. Plasma metabolomics identified novel metabolites associated with risk of type 2 diabetes in two prospective cohorts of Chinese adults.
Qiu G; Zheng Y; Wang H; Sun J; Ma H; Xiao Y; Li Y; Yuan Y; Yang H; Li X; Min X; Zhang C; Xu C; Jiang Y; Zhang X; He M; Yang M; Hu Z; Tang H; Shen H; Hu FB; Pan A; Wu T
Int J Epidemiol; 2016 Oct; 45(5):1507-1516. PubMed ID: 27694567
[TBL] [Abstract][Full Text] [Related]
8. Lysine pathway metabolites and the risk of type 2 diabetes and cardiovascular disease in the PREDIMED study: results from two case-cohort studies.
Razquin C; Ruiz-Canela M; Clish CB; Li J; Toledo E; Dennis C; Liang L; Salas-Huetos A; Pierce KA; Guasch-Ferré M; Corella D; Ros E; Estruch R; Gómez-Gracia E; Fitó M; Lapetra J; Romaguera D; Alonso-Gómez A; Serra-Majem L; Salas-Salvadó J; Hu FB; Martínez-González MA
Cardiovasc Diabetol; 2019 Nov; 18(1):151. PubMed ID: 31722714
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers for predicting type 2 diabetes development-Can metabolomics improve on existing biomarkers?
Savolainen O; Fagerberg B; Vendelbo Lind M; Sandberg AS; Ross AB; Bergström G
PLoS One; 2017; 12(7):e0177738. PubMed ID: 28692646
[TBL] [Abstract][Full Text] [Related]
10. Urinary metabolomics of phenolic compounds reveals biomarkers of type-2 diabetes within the PREDIMED trial.
Domínguez-López I; Lozano-Castellón J; Vallverdú-Queralt A; Jáuregui O; Martínez-González MÁ; Hu FB; Fitó M; Ros E; Estruch R; Lamuela-Raventós RM
Biomed Pharmacother; 2023 Jun; 162():114703. PubMed ID: 37062219
[TBL] [Abstract][Full Text] [Related]
11. Fecal and urinary NMR-based metabolomics unveil an aging signature in mice.
Calvani R; Brasili E; Praticò G; Capuani G; Tomassini A; Marini F; Sciubba F; Finamore A; Roselli M; Marzetti E; Miccheli A
Exp Gerontol; 2014 Jan; 49():5-11. PubMed ID: 24184118
[TBL] [Abstract][Full Text] [Related]
12. Microbial metabolites are associated with a high adherence to a Mediterranean dietary pattern using a
Almanza-Aguilera E; Urpi-Sarda M; Llorach R; Vázquez-Fresno R; Garcia-Aloy M; Carmona F; Sanchez A; Madrid-Gambin F; Estruch R; Corella D; Andres-Lacueva C
J Nutr Biochem; 2017 Oct; 48():36-43. PubMed ID: 28692847
[TBL] [Abstract][Full Text] [Related]
13. Association of cultured myotubes and fasting plasma metabolite profiles with mitochondrial dysfunction in type 2 diabetes subjects.
Abu Bakar MH; Sarmidi MR
Mol Biosyst; 2017 Aug; 13(9):1838-1853. PubMed ID: 28726959
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic pattern analysis after mediterranean diet intervention in a nondiabetic population: a 1- and 3-year follow-up in the PREDIMED study.
Vázquez-Fresno R; Llorach R; Urpi-Sarda M; Lupianez-Barbero A; Estruch R; Corella D; Fitó M; Arós F; Ruiz-Canela M; Salas-Salvadó J; Andres-Lacueva C
J Proteome Res; 2015 Jan; 14(1):531-40. PubMed ID: 25353684
[TBL] [Abstract][Full Text] [Related]
15. Plasma Metabolites From Choline Pathway and Risk of Cardiovascular Disease in the PREDIMED (Prevention With Mediterranean Diet) Study.
Guasch-Ferré M; Hu FB; Ruiz-Canela M; Bulló M; Toledo E; Wang DD; Corella D; Gómez-Gracia E; Fiol M; Estruch R; Lapetra J; Fitó M; Arós F; Serra-Majem L; Ros E; Dennis C; Liang L; Clish CB; Martínez-González MA; Salas-Salvadó J
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080862
[TBL] [Abstract][Full Text] [Related]
16. Glycolysis/gluconeogenesis- and tricarboxylic acid cycle-related metabolites, Mediterranean diet, and type 2 diabetes.
Guasch-Ferré M; Santos JL; Martínez-González MA; Clish CB; Razquin C; Wang D; Liang L; Li J; Dennis C; Corella D; Muñoz-Bravo C; Romaguera D; Estruch R; Santos-Lozano JM; Castañer O; Alonso-Gómez A; Serra-Majem L; Ros E; Canudas S; Asensio EM; Fitó M; Pierce K; Martínez JA; Salas-Salvadó J; Toledo E; Hu FB; Ruiz-Canela M
Am J Clin Nutr; 2020 Apr; 111(4):835-844. PubMed ID: 32060497
[TBL] [Abstract][Full Text] [Related]
17. NMR metabolomics identifies over 60 biomarkers associated with Type II Diabetes impairment in db/db mice.
Mora-Ortiz M; Nuñez Ramos P; Oregioni A; Claus SP
Metabolomics; 2019 Jun; 15(6):89. PubMed ID: 31179513
[TBL] [Abstract][Full Text] [Related]
18. Diabetes and branched-chain amino acids: What is the link?
Bloomgarden Z
J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
[TBL] [Abstract][Full Text] [Related]
19. Plasma Acylcarnitines and Risk of Type 2 Diabetes in a Mediterranean Population at High Cardiovascular Risk.
Guasch-Ferré M; Ruiz-Canela M; Li J; Zheng Y; Bulló M; Wang DD; Toledo E; Clish C; Corella D; Estruch R; Ros E; Fitó M; Arós F; Fiol M; Lapetra J; Serra-Majem L; Liang L; Papandreou C; Dennis C; Martínez-González MA; Hu FB; Salas-Salvadó J
J Clin Endocrinol Metab; 2019 May; 104(5):1508-1519. PubMed ID: 30423132
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
